For licensed medical professionals and compounding pharmacies only. Not for sale to the general public.  ·  787-822-8197
Build Your Order Apply for Wholesale
Build Your Order Products For Clinics For Pharmacies For Brands Quality Wholesale Resources About Contact Apply for Wholesale
Product sourcing reference

FOXO4-DRI

FOXO4-DRI is a retro-inverso peptide studied as a senolytic research tool. It has no approved clinical use; review it strictly as research material.

Reference variants

Add FOXO4-DRI to an order request

Quantities are individual vials (packs of 10). Orders need 100 vials and/or 20 spray bottles in total, mixed across items. Prices are reference estimates captured 2026-10-16; every request is pending eligibility and availability review. Per-unit figures are rounded to the cent from kit pricing, so a final quote may differ slightly.

  • 10mgVial · confirm physical formCAS 2460055-10-9
    $74.75/vialCloseout estimate Regular $149.50. Subject to confirmation; not a stock promise.
    vials, packs of 10

Review your order request · Compare the full catalog

Confirm the exact substance

Retro-inverso peptides use D-amino acids in reversed order to resist degradation. Confirm the exact sequence because minor variants circulate under the same name.

What the review will ask

This is among the highest-cost references in the catalog. Confirm intended use and documentation before committing internal budget to a request.

  • State the facility type, destination state and intended transaction. Do not send patient information.
  • Expect product- and lot-specific documentation to be requested before any material is accepted.
  • A listed price is a reference estimate. Availability, labeling, shipping and terms are confirmed in writing only after review.

Purchasing questions

Has FOXO4-DRI been tested in people?

Published work is preclinical. Do not rely on senolytic claims when assessing a purchase.

Specify the exact research construct

A FOXO4-DRI label is insufficient if documents describe a different sequence or stereochemical arrangement. Research-tool terminology should not be converted into a clinic treatment promise.

Documentation to request

Ask for the full sequence, stereochemistry and analytical characterization. Match the cited experiment to the exact construct rather than a senolytic category.

Regulatory context: FDA: compounding, approval and quality standards. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.

Related guidance: Longevity clinic documentation questions. These references support a review, not a treatment recommendation or supply authorization.

Verify the current regulatory position

Use FDA human drug compounding guidance and applicable state requirements. This reference is not medical or legal advice and does not establish a lawful supply route.

Discuss sourcing requirements
Call Apply for Wholesale